Gawenis, Lara R.
Hodges, Craig A.
McHugh, Daniel R.
Valerio, Dana M.
Miron, Alexander
Cotton, Calvin U.
Liu, Jinghua
Walker, Nancy M.
Strubberg, Ashlee M.
Gillen, Austin E.
Mutolo, Michael J.
Kotzamanis, George
Bosch, Jürgen
Harris, Ann
Drumm, Mitchell L.
Clarke, Lane L. http://orcid.org/0000-0002-4938-6261
Funding for this research was provided by:
Cystic Fibrosis Foundation (HARRIS11G0, HARRIS14P0, CLARKE12G0, CLARKE14G0, CLARKE17G0)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL094585)
Cystic Fibrosis Foundation Therapeutics (CLARKE15XX0)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK048816)
Article History
Received: 14 May 2018
Accepted: 30 July 2019
First Online: 14 August 2019
Competing Interests
: The authors declare no competing interests.